跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
簡 銘賢
教授
,
臨床醫學研究所
合聘教授
,
國際醫學研究碩士學位學程
合聘教授
,
國際醫學研究博士學位學程
合聘教授
,
醫學檢驗暨生物技術學系
合聘教授
,
創新醫學科技研發產業博士學位學程
成員
,
臺北醫學大學癌症轉譯研究中心
成員
,
臺北醫學大學新藥開發研究中心
https://orcid.org/0000-0002-0084-7231
電子郵件
mhchien1976
gmail
com
h-index
6093
引文
44
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2026
每年研究成果
概覽
指紋
網路
專案
(31)
研究成果
(165)
資料集
(13)
類似的個人檔案
(12)
指紋
查看啟用 Ming-Hsien Chien 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Gene Polymorphism
100%
Single-Nucleotide Polymorphism
78%
Cancer Cell
65%
Epidermal Growth Factor Receptor
64%
Programmed Cell Death
63%
Genotyping
56%
Allele
55%
Genetic Polymorphism
55%
Genetic Divergence
52%
Carcinogenesis
51%
Mesenchymal-Epithelial Transition
46%
Snail
46%
Expression Level
42%
Carbonic Anhydrase
39%
Long Non-Coding RNA
33%
Vascular Endothelial Growth Factor C
33%
Protein Kinase B
30%
MicroRNA
30%
Messenger RNA
29%
Proteoglycan
27%
Promoter Region
27%
Interleukin 8
26%
Cadherin
26%
Gene Expression
26%
Piper Betle
25%
Cell Migration
25%
Genetic Variation
24%
Metalloproteinase
22%
Metalloendopeptidase
22%
Signal Transduction
22%
N-Terminus
22%
Wild Type
22%
Disintegrin
21%
Phosphotransferase
21%
Kinase
21%
MMP2
21%
Gelatinase A
21%
Cell Motility
21%
Haplotype
20%
Melatonin
20%
STAT3
20%
MMP9
19%
Gelatinase B
19%
Lipocalin-2
19%
Metalloprotease Inhibitor
19%
N-Acetyltransferase
19%
ADAM9
19%
Cell Invasion
19%
Anticancer
19%
Tumor Progression
19%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
67%
Mouth Squamous Cell Carcinoma
67%
Mouth Cancer
55%
Acute Myeloid Leukemia
53%
Lung Cancer
53%
Phosphotransferase
49%
Protein Kinase B
43%
Gelatinase B
39%
Snail
39%
Neoplasm
38%
Tumor Growth
35%
Epidermal Growth Factor Receptor
33%
Penfluridol
33%
Reactive Oxygen Metabolite
33%
Mitogen Activated Protein Kinase
32%
Cancer Growth
32%
Lung Adenocarcinoma
30%
Caspase 8
28%
Caspase
27%
Gelatinase A
27%
Liver Cell Carcinoma
26%
Prostate Cancer
26%
Melatonin
26%
Acyltransferase
26%
Non Small Cell Lung Cancer
25%
Leukemia
24%
microRNA
24%
Carcinogenesis
23%
Apigenin
21%
Metalloproteinase
20%
Disintegrin
20%
Nuclear Factor
20%
Glioblastoma
19%
Quercetin
19%
Osteosarcoma
19%
Cyclooxygenase 2
19%
Carcinogen
18%
Head and Neck Cancer
17%
Western Blot
16%
Curcumin
15%
Drug Resistance
15%
Solid Malignant Neoplasm
14%
Vasculotropin C
14%
Lymph Node Metastasis
14%
STAT3 Protein
14%
Alternative Complement Pathway C3 C5 Convertase
13%
Repurposing
13%
Renal Cell Carcinoma
13%
Cancer Susceptibility
13%
Promyelocytic Leukemia
13%
Immunology and Microbiology
Lung
68%
Squamous Cell
62%
Susceptibility
48%
Blood Plasma
37%
Cancer Cell
35%
Epidermal Growth Factor
34%
Epithelial Mesenchymal Transition
29%
DNA Polymorphism
27%
Phosphotransferase
27%
Kinase
27%
Ribonucleic Acid
26%
Lipocalin-2
26%
Programmed Cell Death
25%
In Vitro
24%
Single Nucleotide Polymorphism
24%
Signal Transduction
22%
STAT3
21%
Genetic Polymorphism
19%
Carcinoma Cell
19%
Interleukin 17
19%
Cell Proliferation
19%
Blood Level
18%
Antimicrobial Agent
17%
Overall Survival
17%
Amino Terminal Sequence
15%
Endothelial Cells
15%
Allele
14%
Protein RNA Binding
14%
C-Reactive Protein
14%
DNA Damage
13%
Cell Invasion
13%
Xenograft
13%
Therapeutic Target
13%
Malignant Progression
13%
Intercellular Adhesion Molecule 1
13%
Histone
13%
P53
13%
Histamine
13%
CD47
13%
Neck
12%
Colony Formation
12%
Lymph Node
11%
Inflammation
10%
Hepatocellular Carcinoma Cell Line
10%
Gene Expression
10%
Macrophage
10%
mRNA Expression Level
9%
Disease Free Survival
9%
Promoter Region
9%
Tumor Volume
9%
